Cepheid Launches CE Mark Certification Smart CMV™ In Vitro Diagnostic Test for SmartCycler® Platform
The test delivers diagnostics for improved management of immunocompromised patients.
Siemens Highlights Molecular Imaging Solutions for Cardiology, Oncology and Neurology
Siemens' molecular imaging technologies are enabling clinicians and researchers to effectively treat within and further explore these areas.
Tools Improve Treatment Management of AML Patients
Genzyme announces the availability of two new molecular tests for acute myelogenous leukemia.
Xenomics to Present DNA Medical Diagnostic Platform at Rodman & Renshaw Healthcare Conference
CEO Dr. David Tomei to discuss research data and potential product applications of non-Invasive Tr-DNA medical testing technology.
Nanogen Launches Cystic Fibrosis Analyte Specific Reagents
The reagents are designed to detect 23 wild type and mutation sequences associated with cystic fibrosis.
Genzyme Launches Key Test to Monitor Gleevec® Resistance
Genzyme's BCR-ABL Mutation Analysis test will assist physicians in evaluating resistance to therapy.
Genzyme Launches EGFR FISH & JAK2 to Expand Cancer Menu
The tests identify non-small cell lung cancer patients likely to respond to therapies.
AutovaxID™-C Introduced by Biovest International
AutovaxID-C reduces the possibility of cross contamination and allows segregation of patient specific vaccine batches.
Ark Completes Development of oxLDL Diagnostic Kit
The diagnostic kit will be used to predict whether an individual is at risk of having a heart attack.
PRIDE, An Open Source Database of Protein Identifications
PRIDE is designed to exploit the growing mass of information on how the body's complement of proteins is altered in many disease states.